• Policy & Insight

NHS staff shortages: What’s needed to build a sustainable cancer workforce?

We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%. We’ve estimated it will cost HEE between £142 million and £260 million more than it already invests to grow the key cancer professions by 45%.

12 October 2020

• Health & Medicine
• Science & Technology

Scientists develop new precision medicine approach for pancreatic cancer

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

12 October 2020

• For Researchers

Researcher voices: How funders can tackle racial bias and inequality in cancer research

Four Black researchers share advice on how cancer research funders can tackle racial bias and racial inequality. Four Black researchers share advice on how cancer research funders can tackle racial bias and racial inequality.

12 October 2020

• Health & Medicine
• Science & Technology

Vital rethinking in cancer early detection needed to save lives

The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer. The Cancer Research UK Roadmap sets out a plan to overcome the challenges hampering early detection of cancer.

6 October 2020

• Health & Medicine

New drug targeting high-risk children’s cancer is ready for trials

A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma. A new drug that has passed safety tests in adults is likely to be effective against the aggressive childhood cancer neuroblastoma.

5 October 2020

• Health & Medicine

News digest – HPV vaccine, 1 million breast screenings missed and prostate cancer treatment

Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years." Results from a new drug trial have found “one of the most promising breakthroughs for patients with this type of breast cancer in the last 20 years."

3 October 2020

• Health & Medicine

HPV vaccine reduces cervical cancer risk

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.   Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

1 October 2020

• For Researchers

Viewpoint: My team’s experience with the CRUK Open Lab Initiative

Francesca Ciccarelli tells us about her team’s experience with the CRUK Open Lab Initiative, which helps research groups connect with each other. Francesca Ciccarelli tells us about her team’s experience with the CRUK Open Lab Initiative, which helps research groups connect with each other.

1 October 2020

• Health & Medicine

UK health inequalities: 20,000 more cancer cases a year in the most deprived areas

New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK. New figures released today reveal that there are around 20,000 extra cancer cases each year in more deprived areas of the UK.

30 September 2020

• For Researchers

Viewpoint: How we’re keeping children’s cancer trials going

Lead nurse Tracey Crowe shares her experience of caring for children with cancer during the COVID-19 pandemic and what to consider to keep clinical trials going Lead nurse Tracey Crowe shares her experience of caring for children with cancer during the COVID-19 pandemic and what to consider to keep clinical trials going

29 September 2020

• Policy & Insight

Opinion: 'Let’s not be short-sighted – the UK’s medical research charities need urgent support'

Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding. Today’s new figures, from the UK’s National Cancer Research Institute, project a devastating 24% drop in the UK’s overall cancer research spending this year, driven by a 46% fall in charity sector funding.

24 September 2020